drugset / Trial / NCT00031044

Adding New Drugs for HIV Infected Patients Failing Current Therapy

NCT00031044

RandomizedParallel-groupOpen-labelTreatment

Summary

Even though powerful anti-HIV drug combinations have been successful in patients with little or no prior anti-HIV therapy, studies have shown that these treatments are less effective in patients who have been treated with nucleoside analogues. This study will test the safety and effectiveness of adding one or two new drugs to a personalized anti-HIV regimen for patients whose previous HIV treatments have failed.

Timeline

Start
Primary completion
Completion
2004-11

Drugs

EvaluationDrugModalityDoseRoute
Subject amdoxovir Small molecule 300 mg Oral
Background Enfuvirtide Peptide Other